Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris

Scandinavian Cardiovascular Journal

Volumn 42, Issue 3, 2008, Pages 214-221

  Gravning, Jørgen ^a   Ueland, Thor ^b   Mørkrid, Lars ^a   Endresen, Knut ^a,c   Aaberge, Lars ^a,c   Kjekshus, John ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Acute coronary syndrome; Myocardial injury; Percutaneous coronary intervention; Prognosis

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I; UP-REGULATION;

EID: 45849094093     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430801932824     Document Type: Article

References (32)

1. Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, et al. Management and outcome of patients with established coronary artery disease: The Euro Heart Survey on coronary revascularization. Eur Heart J. 2005;26:1169-79.
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. New Engl JMed. 1994;331:496-501.
3. Odell A, Gudnason T, Andersson T, Jidbratt H, Grip L. One-year outcome after percutaneous coronary intervention for stable and unstable angina pectoris with or without application of general usage of stents in unselected European patient groups. Am J Cardiol. 2002;90:112-8.
4. Bentivoglio LG, Detre K, Yeh W, Williams DO, Kelsey SF, Faxon DP. Outcome of percutaneous transluminal coronary angioplasty in subsets of unstable angina pectoris. A report of the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol. 1994;24:1195-206.
5. Giedd KN, Bergmann SR. Myocardial perfusion imaging following percutaneous coronary intervention: The importance of restenosis, disease progression, and directed reintervention. J Am Coll Cardiol. 2004;43:328-36.
6. Tardiff BE, Califf RM, Tcheng JE, Lincoff AM, Sigmon KN, Harrington RA, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol. 1999;33:88-96.
7. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J. 2005;26:2493-519.
8. Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J. 2004;25:313-21.
9. Harris BM, Nageh T, Marsden JT, Thomas MR, Sherwood RA. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann Clin Biochem. 2000;37:764-9.
10. Cantor WJ, Newby LK, Christenson RH, Tuttle RH, Hasselblad V, Armstrong PW, et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol. 2002;39:1738-44.
11. Kizer JR, Muttrej MR, Matthai WH, McConnell J, Nardone H, Sonel AF, et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J. 2003;24:1314-22.
12. Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR. Cardiac troponin Tand I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol. 2003;92:285-93.
13. Bodi V, Sanchis J, Llacer A, Facila L, Nunez J, Bertomeu V, et al. Risk stratification in non-ST elevation acute coronary syndromes: Predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine. Int J Cardiol. 2005;98:277-83.
14. Bertinchant JP, Polge A, Ledermann B, Genet L, Fabbro-Peray P, Raczka F, et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol. 1999;84:51-7.
15. Hamm CW, Katus HA. New biochemical markers for myocardial cell injury. Curr Opin Cardiol. 1995;10:355-60.
16. Mair J. Progress in myocardial damage detection: New biochemical markers for clinicians. Crit Rev Clin Lab Sci. 1997;34:1-66.
17. Venge P, Lagerqvist B, Diderholm E, Lindahl B, Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol. 2002;89:1035-41.
18. Antman E, Bassand JP, Klein W, Ohman M, Lopez Sendon JL, Ryden L, et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/American College of Cardiology Committee. J Am Coll Cardiol. 2000;36:959-69.
19. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. The FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. New Engl J Med. 2000;343:1139-47.
20. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. New Engl J Med. 1996;335:1333-42.
21. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: A community-based cohort study. Circulation. 2006;113:1071-8.
22. Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001;103:2780-3.
23. Elbaz M, Carrie D, Baudeux JL, Arnal JF, Maupas E, Lotterie JA, et al. High frequency of endothelial vasomotor dysfunction after acute coronary syndromes in non-culprit and angiographically normal coronary arteries: A reversible phenomenon. Atherosclerosis. 2005;181:311-9.
24. Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation. 2002;106:804-8.
25. Benamer H, Steg PG, Benessiano J, Vicaut E, Gaultier CJ, Aubry P, et al. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. Am Heart J. 1999;137:815-20.
26. Ricciardi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, Parker MA, et al. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J. 2003;145:522-8.
27. Heeschen C, van den Brand MJ, Hamm CW, Simoons ML. Angiographic findings in patients with refractory unstable angina according to Troponin T status. Circulation. 1999;100:1509-14.
28. Okmen E, Sanli A, Uyarel H, Dayi S, Tartan Z, Cam N. Effects of glycoprotein IIb/IIIa receptor inhibition with tirofiban on minor myocardial damage in angiographically successful percutaneous coronary angioplasty. Cardiology. 2004;102:18-23.
29. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 1999;354:1757-62.
30. Rasoul S, Ottervanger JP, de Boer MJ, Miedema K, Hoorntje JCA, Gosselink M, et al. A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: Results of the ELISA-2 trial. Eur Heart J. 2006;27:1401-7.
31. Atar I, Korkmaz ME, Atar I, Gulmez O, Ozin B, Bozbas H, et al. Effects of metoprolol therapy on cardiac troponin-I levels after elective percutaneous coronary interventions. Eur Heart J. 2006;27:547-52.
32. Lee CH, Low A, Tai BC, Co M, Chan MY, Lim J, et al. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: A prospective randomized study. Eur Heart J. 2007;28:19-25.